NCT04854174View on ClinicalTrials.gov

A Food Effect Study of ZN-d5 in Healthy Female Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

June 13, 2021

Primary Completion Date

June 30, 2021

Study Completion Date

July 5, 2021

Conditions

Healthy Volunteers

Interventions

DRUG

ZN-d5

Oral agent; 25 mg formulation

Trial Locations (1)

Unknown

Site # 2801, Christchurch

All Listed Sponsors

lead

K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.

INDUSTRY